Wan et al. reported that HLA-G expression in tumors not only correlates with lower numbers of tumor infiltrating NK cells but also inhibits the cytotoxic potential of residing NK cells probably by binding to their inhibitory receptor LILRB1 [187]. Here, LILRB1 is linked to neoplasm.